<?xml version="1.0" encoding="UTF-8"?>
<ref id="B78-marinedrugs-16-00256" class="ref">
 <label class="label">78.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Homsi</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Bedikian</surname>
    <given-names class="given-names">A.Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kim</surname>
    <given-names class="given-names">K.B.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Papadopoulos</surname>
    <given-names class="given-names">N.E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hwu</surname>
    <given-names class="given-names">W.J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mahoney</surname>
    <given-names class="given-names">S.L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hwu</surname>
    <given-names class="given-names">P.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients</article-title>
  <source class="source">Melanoma Res.</source>
  <year class="year">2009</year>
  <volume class="volume">19</volume>
  <fpage class="fpage">238</fpage>
  <lpage class="lpage">242</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1097/CMR.0b013e32832a1e2f</pub-id>
  <?supplied-pmid 19521262?>
  <pub-id pub-id-type="pmid" class="pub-id">19521262</pub-id>
 </element-citation>
</ref>
